Implantable Chemical Sensor with Anti-Inflammatory Barrier
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current implantable medical devices (IMDs) face challenges in continuously monitoring physiological analyte concentrations, such as potassium, due to foreign body responses that lead to the encasement of sensors in avascular pockets, disrupting their functionality.
Innovation Solution
The development of an implantable medical device with a chemical sensor featuring a polymeric matrix-based outer barrier layer that is permeable to specific ions, an optical excitation assembly, and an optical detection assembly, along with an active agent eluting material to attenuate the foreign body response and improve sensor functionality.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If an implantable chemical sensor is placed in the body to continuously monitor analyte concentrations, then the ability to obtain physiological data is improved, but the foreign body response encasement in avascular pockets disrupts sensor functionality
Solution Approach 1:
The patent applies preliminary anti-action by incorporating anti-inflammatory drugs into the barrier layer before implantation. These drugs are released in advance to prevent or reduce the foreign body response, thereby maintaining sensor functionality over time. The barrier layer is pre-loaded with therapeutic agents that actively counteract the harmful encapsulation process before it fully develops.
Solution Approach 2:
The barrier layer serves as an intermediary between the sensor and the physiological environment. It mediates the interaction by providing selective permeability to ions while incorporating anti-inflammatory agents that reduce the foreign body response. This intermediary layer protects the sensor while maintaining necessary analyte transport.
2Reliability
If a barrier layer is added to protect the sensor and reduce foreign body response, then sensor protection is improved, but the barrier may impede analyte transport to the sensing element
Solution Approach 1:
The barrier layer is designed as a porous structure that allows selective transport of physiological analytes while providing mechanical protection. The porous architecture enables ion diffusion through the barrier to reach the sensing element, maintaining measurement precision while offering structural support and drug delivery capabilities.
Solution Approach 2:
The barrier layer is constructed as a composite material combining protective structural components with ion-permeable regions. This composite structure integrates mechanical strength with selective permeability, allowing the barrier to protect the sensor while permitting necessary analyte transport for accurate detection.
3Measurement precision
If blood draws are performed at medical facilities to measure analyte concentrations, then measurement accuracy is improved, but patient convenience and frequency of monitoring deteriorate
Solution Approach 1:
The implantable sensor system enables self-service monitoring by continuously measuring analyte concentrations within the patient's body. The sensor autonomously performs measurements and transmits data without requiring patient action beyond initial implantation, eliminating the need for frequent hospital visits while maintaining clinical-grade measurement accuracy.
Solution Approach 2:
The implantable sensor provides continuous monitoring of analyte concentrations, transforming sporadic clinical measurements into an ongoing data stream. This continuous action enables real-time physiological monitoring, improving both patient convenience and the richness of clinical data compared to intermittent blood draws.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This configuration allows for continuous monitoring of analyte concentrations, reducing the thickness of avascular pockets and enhancing the sensor's communication with the physiological environment, thereby providing a richer data set for medical professionals without the need for frequent patient visits.
Implementation Method 1
The top of the outer barrier layer can be created from a polymeric matrix permeable to physiological analytes
Implementation Method 2
a polymeric matrix permeable to sodium ions, potassium ions, hydronium ions, urea and creatinine
Implementation Method 3
The chemical sensor can include an optical excitation assembly configured to illuminate the sensing element
Implementation Method 4
The chemical sensor can also include an optical detection assembly configured to receive light from the sensing element
Data Source
AI summary
Embodiments herein relate to chemical sensors for detecting a physiological analyte. In an embodiment, an implantable medical device including a chemical sensor for detecting an ion concentration in a bodily fluid is provided. The chemical sensor can include a sensing element having an outer barrier layer forming a top, a bottom, and opposed sides, where the top of the outer barrier layer can be created from a polymeric matrix permeable to sodium ions, potassium ions, and hydronium ions. An active agent can be disposed within the top of the outer barrier layer, the active agent having anti-inflammatory effects. The chemical sensor can include an optical excitation assembly configured to illuminate the sensing element. The chemical sensor can also include an optical detection assembly configured to receive light from the sensing element. Other embodiments are also included herein.